nodes	percent_of_prediction	percent_of_DWPC	metapath
Vismodegib—ALB—chronic obstructive pulmonary disease	0.296	1	CbGaD
Vismodegib—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0497	0.108	CbGbCtD
Vismodegib—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0497	0.108	CbGbCtD
Vismodegib—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0449	0.0979	CbGbCtD
Vismodegib—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0413	0.0901	CbGbCtD
Vismodegib—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0413	0.0901	CbGbCtD
Vismodegib—ALB—Prednisone—chronic obstructive pulmonary disease	0.0322	0.0702	CbGbCtD
Vismodegib—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0317	0.0691	CbGbCtD
Vismodegib—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0313	0.0683	CbGbCtD
Vismodegib—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0214	0.0467	CbGbCtD
Vismodegib—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0209	0.0455	CbGbCtD
Vismodegib—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0204	0.0446	CbGbCtD
Vismodegib—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0182	0.0397	CbGbCtD
Vismodegib—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0178	0.0389	CbGbCtD
Vismodegib—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0168	0.0367	CbGbCtD
Vismodegib—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0107	0.0233	CbGbCtD
Vismodegib—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0101	0.022	CbGbCtD
Vismodegib—SHH—respiratory system—chronic obstructive pulmonary disease	0.00431	0.177	CbGeAlD
Vismodegib—SHH—connective tissue—chronic obstructive pulmonary disease	0.00379	0.156	CbGeAlD
Vismodegib—Musculoskeletal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00361	0.0353	CcSEcCtD
Vismodegib—SMO—respiratory system—chronic obstructive pulmonary disease	0.00301	0.124	CbGeAlD
Vismodegib—SMO—connective tissue—chronic obstructive pulmonary disease	0.00265	0.109	CbGeAlD
Vismodegib—SMO—bronchus—chronic obstructive pulmonary disease	0.00248	0.102	CbGeAlD
Vismodegib—SHH—lung—chronic obstructive pulmonary disease	0.00229	0.0939	CbGeAlD
Vismodegib—SMO—trachea—chronic obstructive pulmonary disease	0.00223	0.0914	CbGeAlD
Vismodegib—SMO—lung—chronic obstructive pulmonary disease	0.0016	0.0657	CbGeAlD
Vismodegib—Weight decreased—Roflumilast—chronic obstructive pulmonary disease	0.00153	0.0149	CcSEcCtD
Vismodegib—Etoricoxib—CYP1A2—chronic obstructive pulmonary disease	0.00143	0.643	CrCbGaD
Vismodegib—Blood potassium decreased—Prednisone—chronic obstructive pulmonary disease	0.00141	0.0138	CcSEcCtD
Vismodegib—Connective tissue disorder—Roflumilast—chronic obstructive pulmonary disease	0.00133	0.013	CcSEcCtD
Vismodegib—Musculoskeletal pain—Salbutamol—chronic obstructive pulmonary disease	0.0013	0.0128	CcSEcCtD
Vismodegib—Pain in extremity—Tiotropium—chronic obstructive pulmonary disease	0.00123	0.012	CcSEcCtD
Vismodegib—Abdominal pain upper—Aminophylline—chronic obstructive pulmonary disease	0.00119	0.0116	CcSEcCtD
Vismodegib—Hypokalaemia—Aminophylline—chronic obstructive pulmonary disease	0.00118	0.0116	CcSEcCtD
Vismodegib—Malnutrition—Roflumilast—chronic obstructive pulmonary disease	0.00118	0.0115	CcSEcCtD
Vismodegib—Dysgeusia—Roflumilast—chronic obstructive pulmonary disease	0.00115	0.0113	CcSEcCtD
Vismodegib—Dehydration—Tiotropium—chronic obstructive pulmonary disease	0.00114	0.0112	CcSEcCtD
Vismodegib—Back pain—Roflumilast—chronic obstructive pulmonary disease	0.00114	0.0111	CcSEcCtD
Vismodegib—Muscle spasms—Roflumilast—chronic obstructive pulmonary disease	0.00113	0.0111	CcSEcCtD
Vismodegib—Myalgia—Roflumilast—chronic obstructive pulmonary disease	0.001	0.0098	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.000994	0.00973	CcSEcCtD
Vismodegib—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.000941	0.00921	CcSEcCtD
Vismodegib—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.000932	0.00912	CcSEcCtD
Vismodegib—Dehydration—Arformoterol—chronic obstructive pulmonary disease	0.000921	0.00902	CcSEcCtD
Vismodegib—Dehydration—Formoterol—chronic obstructive pulmonary disease	0.000921	0.00902	CcSEcCtD
Vismodegib—Hypokalaemia—Formoterol—chronic obstructive pulmonary disease	0.000902	0.00882	CcSEcCtD
Vismodegib—Hypokalaemia—Arformoterol—chronic obstructive pulmonary disease	0.000902	0.00882	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.000874	0.00856	CcSEcCtD
Vismodegib—Aspartate aminotransferase increased—Montelukast—chronic obstructive pulmonary disease	0.000874	0.00855	CcSEcCtD
Vismodegib—Abdominal pain upper—Salbutamol—chronic obstructive pulmonary disease	0.000855	0.00836	CcSEcCtD
Vismodegib—Hypokalaemia—Salbutamol—chronic obstructive pulmonary disease	0.000851	0.00833	CcSEcCtD
Vismodegib—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.000845	0.00827	CcSEcCtD
Vismodegib—Connective tissue disorder—Tiotropium—chronic obstructive pulmonary disease	0.000835	0.00817	CcSEcCtD
Vismodegib—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.000834	0.00816	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000828	0.00811	CcSEcCtD
Vismodegib—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.000827	0.0081	CcSEcCtD
Vismodegib—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.000821	0.00803	CcSEcCtD
Vismodegib—Sorafenib—CYP1A2—chronic obstructive pulmonary disease	0.000798	0.357	CrCbGaD
Vismodegib—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.000796	0.00779	CcSEcCtD
Vismodegib—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.000785	0.00768	CcSEcCtD
Vismodegib—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000759	0.00742	CcSEcCtD
Vismodegib—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.000739	0.00724	CcSEcCtD
Vismodegib—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.000715	0.007	CcSEcCtD
Vismodegib—ORM1—lung—chronic obstructive pulmonary disease	0.000699	0.0287	CbGeAlD
Vismodegib—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000688	0.00674	CcSEcCtD
Vismodegib—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.000674	0.00659	CcSEcCtD
Vismodegib—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.000674	0.00659	CcSEcCtD
Vismodegib—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.00066	0.00646	CcSEcCtD
Vismodegib—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000657	0.00642	CcSEcCtD
Vismodegib—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.000636	0.00622	CcSEcCtD
Vismodegib—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.000629	0.00616	CcSEcCtD
Vismodegib—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.000629	0.00616	CcSEcCtD
Vismodegib—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000628	0.00614	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000625	0.00612	CcSEcCtD
Vismodegib—Amenorrhoea—Prednisone—chronic obstructive pulmonary disease	0.000611	0.00598	CcSEcCtD
Vismodegib—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00061	0.00597	CcSEcCtD
Vismodegib—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000605	0.00592	CcSEcCtD
Vismodegib—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000604	0.00592	CcSEcCtD
Vismodegib—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.000597	0.00584	CcSEcCtD
Vismodegib—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.000597	0.00584	CcSEcCtD
Vismodegib—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000592	0.00579	CcSEcCtD
Vismodegib—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000586	0.00574	CcSEcCtD
Vismodegib—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000584	0.00572	CcSEcCtD
Vismodegib—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000584	0.00572	CcSEcCtD
Vismodegib—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000577	0.00565	CcSEcCtD
Vismodegib—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000577	0.00565	CcSEcCtD
Vismodegib—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000574	0.00561	CcSEcCtD
Vismodegib—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000574	0.00561	CcSEcCtD
Vismodegib—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00057	0.00558	CcSEcCtD
Vismodegib—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000563	0.00551	CcSEcCtD
Vismodegib—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000563	0.00551	CcSEcCtD
Vismodegib—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000562	0.0055	CcSEcCtD
Vismodegib—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000556	0.00544	CcSEcCtD
Vismodegib—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000552	0.0054	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00055	0.00538	CcSEcCtD
Vismodegib—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000545	0.00533	CcSEcCtD
Vismodegib—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000542	0.0053	CcSEcCtD
Vismodegib—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000531	0.0052	CcSEcCtD
Vismodegib—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000523	0.00512	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000521	0.0051	CcSEcCtD
Vismodegib—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000516	0.00505	CcSEcCtD
Vismodegib—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000508	0.00497	CcSEcCtD
Vismodegib—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000508	0.00497	CcSEcCtD
Vismodegib—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000508	0.00497	CcSEcCtD
Vismodegib—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000508	0.00497	CcSEcCtD
Vismodegib—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000506	0.00495	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000505	0.00494	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000505	0.00494	CcSEcCtD
Vismodegib—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000498	0.00487	CcSEcCtD
Vismodegib—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000498	0.00487	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000494	0.00484	CcSEcCtD
Vismodegib—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000493	0.00483	CcSEcCtD
Vismodegib—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00048	0.00469	CcSEcCtD
Vismodegib—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00048	0.00469	CcSEcCtD
Vismodegib—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000478	0.00467	CcSEcCtD
Vismodegib—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000478	0.00467	CcSEcCtD
Vismodegib—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000477	0.00467	CcSEcCtD
Vismodegib—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000473	0.00463	CcSEcCtD
Vismodegib—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000473	0.00463	CcSEcCtD
Vismodegib—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000468	0.00458	CcSEcCtD
Vismodegib—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000463	0.00453	CcSEcCtD
Vismodegib—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000453	0.00443	CcSEcCtD
Vismodegib—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000451	0.00441	CcSEcCtD
Vismodegib—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000447	0.00437	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000444	0.00434	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000444	0.00434	CcSEcCtD
Vismodegib—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000438	0.00428	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000435	0.00425	CcSEcCtD
Vismodegib—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000429	0.0042	CcSEcCtD
Vismodegib—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000429	0.0042	CcSEcCtD
Vismodegib—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000427	0.00418	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00042	0.00411	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00042	0.00411	CcSEcCtD
Vismodegib—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00042	0.00411	CcSEcCtD
Vismodegib—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00042	0.00411	CcSEcCtD
Vismodegib—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00042	0.00411	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000419	0.0041	CcSEcCtD
Vismodegib—ABCG2—lung—chronic obstructive pulmonary disease	0.000419	0.0172	CbGeAlD
Vismodegib—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000416	0.00408	CcSEcCtD
Vismodegib—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000416	0.00408	CcSEcCtD
Vismodegib—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000416	0.00408	CcSEcCtD
Vismodegib—Pain—Formoterol—chronic obstructive pulmonary disease	0.000416	0.00408	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000412	0.00403	CcSEcCtD
Vismodegib—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000411	0.00402	CcSEcCtD
Vismodegib—Pain—Montelukast—chronic obstructive pulmonary disease	0.000408	0.00399	CcSEcCtD
Vismodegib—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000407	0.00398	CcSEcCtD
Vismodegib—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000405	0.00396	CcSEcCtD
Vismodegib—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000403	0.00395	CcSEcCtD
Vismodegib—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000403	0.00394	CcSEcCtD
Vismodegib—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.0004	0.00391	CcSEcCtD
Vismodegib—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000398	0.0039	CcSEcCtD
Vismodegib—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000398	0.0039	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000397	0.00389	CcSEcCtD
Vismodegib—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000396	0.00388	CcSEcCtD
Vismodegib—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000393	0.00385	CcSEcCtD
Vismodegib—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000393	0.00385	CcSEcCtD
Vismodegib—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00039	0.00382	CcSEcCtD
Vismodegib—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000389	0.016	CbGeAlD
Vismodegib—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000385	0.00377	CcSEcCtD
Vismodegib—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000385	0.00377	CcSEcCtD
Vismodegib—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000384	0.00375	CcSEcCtD
Vismodegib—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00038	0.00372	CcSEcCtD
Vismodegib—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00038	0.00372	CcSEcCtD
Vismodegib—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00038	0.00372	CcSEcCtD
Vismodegib—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000377	0.00369	CcSEcCtD
Vismodegib—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000376	0.00368	CcSEcCtD
Vismodegib—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000364	0.00356	CcSEcCtD
Vismodegib—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000358	0.00351	CcSEcCtD
Vismodegib—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000355	0.00347	CcSEcCtD
Vismodegib—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000349	0.00342	CcSEcCtD
Vismodegib—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000349	0.00342	CcSEcCtD
Vismodegib—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000345	0.00337	CcSEcCtD
Vismodegib—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000345	0.00337	CcSEcCtD
Vismodegib—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000342	0.00335	CcSEcCtD
Vismodegib—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000337	0.0033	CcSEcCtD
Vismodegib—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000333	0.00326	CcSEcCtD
Vismodegib—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000333	0.00326	CcSEcCtD
Vismodegib—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00033	0.00323	CcSEcCtD
Vismodegib—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000326	0.00319	CcSEcCtD
Vismodegib—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000325	0.00318	CcSEcCtD
Vismodegib—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000315	0.00308	CcSEcCtD
Vismodegib—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00031	0.00303	CcSEcCtD
Vismodegib—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00031	0.00303	CcSEcCtD
Vismodegib—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000307	0.003	CcSEcCtD
Vismodegib—Rash—Formoterol—chronic obstructive pulmonary disease	0.000307	0.003	CcSEcCtD
Vismodegib—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000307	0.003	CcSEcCtD
Vismodegib—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000307	0.003	CcSEcCtD
Vismodegib—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000305	0.00298	CcSEcCtD
Vismodegib—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000303	0.00297	CcSEcCtD
Vismodegib—Rash—Montelukast—chronic obstructive pulmonary disease	0.000301	0.00294	CcSEcCtD
Vismodegib—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.0003	0.00294	CcSEcCtD
Vismodegib—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000292	0.00286	CcSEcCtD
Vismodegib—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00029	0.00284	CcSEcCtD
Vismodegib—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00029	0.00283	CcSEcCtD
Vismodegib—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000289	0.00283	CcSEcCtD
Vismodegib—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000289	0.00283	CcSEcCtD
Vismodegib—ABCB1—trachea—chronic obstructive pulmonary disease	0.000287	0.0118	CbGeAlD
Vismodegib—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000283	0.00277	CcSEcCtD
Vismodegib—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000273	0.00267	CcSEcCtD
Vismodegib—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000265	0.00259	CcSEcCtD
Vismodegib—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000238	0.00233	CcSEcCtD
Vismodegib—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000235	0.0023	CcSEcCtD
Vismodegib—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000226	0.00221	CcSEcCtD
Vismodegib—ABCB1—lung—chronic obstructive pulmonary disease	0.000207	0.00848	CbGeAlD
Vismodegib—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.0002	0.00196	CcSEcCtD
Vismodegib—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.0002	0.00196	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000199	0.00194	CcSEcCtD
Vismodegib—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000188	0.00184	CcSEcCtD
Vismodegib—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000186	0.00182	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000175	0.00171	CcSEcCtD
Vismodegib—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000169	0.00165	CcSEcCtD
Vismodegib—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000167	0.00163	CcSEcCtD
Vismodegib—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.00163	CcSEcCtD
Vismodegib—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.00163	CcSEcCtD
Vismodegib—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000165	0.00162	CcSEcCtD
Vismodegib—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000164	0.0016	CcSEcCtD
Vismodegib—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000157	0.00153	CcSEcCtD
Vismodegib—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000157	0.00153	CcSEcCtD
Vismodegib—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000152	0.00148	CcSEcCtD
Vismodegib—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000138	0.00135	CcSEcCtD
Vismodegib—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000136	0.00133	CcSEcCtD
Vismodegib—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000131	0.00128	CcSEcCtD
Vismodegib—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000122	0.00119	CcSEcCtD
Vismodegib—Rash—Prednisone—chronic obstructive pulmonary disease	0.000121	0.00118	CcSEcCtD
Vismodegib—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000121	0.00118	CcSEcCtD
Vismodegib—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000114	0.00111	CcSEcCtD
Vismodegib—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.98e-05	0.000682	CbGpPWpGaD
Vismodegib—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.87e-05	0.000673	CbGpPWpGaD
Vismodegib—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.81e-05	0.000668	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	7.81e-05	0.000668	CbGpPWpGaD
Vismodegib—SHH—Disease—ERBB3—chronic obstructive pulmonary disease	7.77e-05	0.000664	CbGpPWpGaD
Vismodegib—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.72e-05	0.00066	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	7.58e-05	0.000648	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—APIP—chronic obstructive pulmonary disease	7.51e-05	0.000642	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	7.41e-05	0.000633	CbGpPWpGaD
Vismodegib—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	7.4e-05	0.000633	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	7.32e-05	0.000626	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—KL—chronic obstructive pulmonary disease	7.26e-05	0.000621	CbGpPWpGaD
Vismodegib—ALB—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	7.24e-05	0.000619	CbGpPWpGaD
Vismodegib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	7.23e-05	0.000618	CbGpPWpGaD
Vismodegib—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	7.13e-05	0.000609	CbGpPWpGaD
Vismodegib—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.12e-05	0.000609	CbGpPWpGaD
Vismodegib—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.02e-05	0.0006	CbGpPWpGaD
Vismodegib—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	6.9e-05	0.00059	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—KL—chronic obstructive pulmonary disease	6.88e-05	0.000588	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	6.86e-05	0.000586	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	6.75e-05	0.000577	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	6.71e-05	0.000573	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	6.71e-05	0.000573	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	6.7e-05	0.000573	CbGpPWpGaD
Vismodegib—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.65e-05	0.000569	CbGpPWpGaD
Vismodegib—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.56e-05	0.000561	CbGpPWpGaD
Vismodegib—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.49e-05	0.000555	CbGpPWpGaD
Vismodegib—SHH—Disease—NOS2—chronic obstructive pulmonary disease	6.48e-05	0.000554	CbGpPWpGaD
Vismodegib—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.4e-05	0.000547	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	6.35e-05	0.000543	CbGpPWpGaD
Vismodegib—ALB—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	6.12e-05	0.000523	CbGpPWpGaD
Vismodegib—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.11e-05	0.000523	CbGpPWpGaD
Vismodegib—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.03e-05	0.000515	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	6.02e-05	0.000515	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.99e-05	0.000512	CbGpPWpGaD
Vismodegib—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.94e-05	0.000508	CbGpPWpGaD
Vismodegib—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.86e-05	0.000501	CbGpPWpGaD
Vismodegib—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.86e-05	0.000501	CbGpPWpGaD
Vismodegib—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.8e-05	0.000495	CbGpPWpGaD
Vismodegib—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.72e-05	0.000489	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.68e-05	0.000485	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.49e-05	0.000469	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.48e-05	0.000468	CbGpPWpGaD
Vismodegib—SHH—Disease—SERPINE1—chronic obstructive pulmonary disease	5.46e-05	0.000467	CbGpPWpGaD
Vismodegib—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.46e-05	0.000466	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	5.45e-05	0.000466	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.44e-05	0.000465	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	5.43e-05	0.000464	CbGpPWpGaD
Vismodegib—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.42e-05	0.000463	CbGpPWpGaD
Vismodegib—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.38e-05	0.00046	CbGpPWpGaD
Vismodegib—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.34e-05	0.000457	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.24e-05	0.000448	CbGpPWpGaD
Vismodegib—SHH—Disease—NOS3—chronic obstructive pulmonary disease	5.21e-05	0.000445	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	5.21e-05	0.000445	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.19e-05	0.000444	CbGpPWpGaD
Vismodegib—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.17e-05	0.000442	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.16e-05	0.000441	CbGpPWpGaD
Vismodegib—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.15e-05	0.00044	CbGpPWpGaD
Vismodegib—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.1e-05	0.000436	CbGpPWpGaD
Vismodegib—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.09e-05	0.000435	CbGpPWpGaD
Vismodegib—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	5.09e-05	0.000435	CbGpPWpGaD
Vismodegib—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	4.98e-05	0.000426	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	4.98e-05	0.000426	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.98e-05	0.000425	CbGpPWpGaD
Vismodegib—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.98e-05	0.000425	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.97e-05	0.000425	CbGpPWpGaD
Vismodegib—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	4.94e-05	0.000422	CbGpPWpGaD
Vismodegib—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.91e-05	0.00042	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.87e-05	0.000416	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—GC—chronic obstructive pulmonary disease	4.84e-05	0.000414	CbGpPWpGaD
Vismodegib—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	4.75e-05	0.000406	CbGpPWpGaD
Vismodegib—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.72e-05	0.000403	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	4.66e-05	0.000399	CbGpPWpGaD
Vismodegib—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.65e-05	0.000398	CbGpPWpGaD
Vismodegib—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	4.64e-05	0.000396	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.62e-05	0.000395	CbGpPWpGaD
Vismodegib—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	4.57e-05	0.000391	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.5e-05	0.000385	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	4.41e-05	0.000377	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	4.39e-05	0.000375	CbGpPWpGaD
Vismodegib—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	4.36e-05	0.000372	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	4.35e-05	0.000372	CbGpPWpGaD
Vismodegib—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.28e-05	0.000366	CbGpPWpGaD
Vismodegib—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.22e-05	0.000361	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	4.16e-05	0.000356	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	4.06e-05	0.000347	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	4.05e-05	0.000346	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	4.02e-05	0.000343	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.01e-05	0.000342	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	3.96e-05	0.000338	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.86e-05	0.00033	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.82e-05	0.000327	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.8e-05	0.000325	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	3.8e-05	0.000324	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	3.78e-05	0.000323	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	3.77e-05	0.000322	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.65e-05	0.000312	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.62e-05	0.00031	CbGpPWpGaD
Vismodegib—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.57e-05	0.000305	CbGpPWpGaD
Vismodegib—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.52e-05	0.000301	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.46e-05	0.000296	CbGpPWpGaD
Vismodegib—SHH—Disease—TGFB1—chronic obstructive pulmonary disease	3.45e-05	0.000295	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	3.38e-05	0.000289	CbGpPWpGaD
Vismodegib—SHH—Disease—EGFR—chronic obstructive pulmonary disease	3.38e-05	0.000289	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.33e-05	0.000284	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.31e-05	0.000283	CbGpPWpGaD
Vismodegib—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.28e-05	0.000281	CbGpPWpGaD
Vismodegib—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.24e-05	0.000277	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.24e-05	0.000277	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	3.21e-05	0.000275	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	3.19e-05	0.000273	CbGpPWpGaD
Vismodegib—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.11e-05	0.000266	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.09e-05	0.000264	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.08e-05	0.000263	CbGpPWpGaD
Vismodegib—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.07e-05	0.000263	CbGpPWpGaD
Vismodegib—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.07e-05	0.000262	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.07e-05	0.000262	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.06e-05	0.000262	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	3.05e-05	0.000261	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.05e-05	0.00026	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	3.01e-05	0.000257	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GC—chronic obstructive pulmonary disease	2.99e-05	0.000255	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.97e-05	0.000254	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.93e-05	0.00025	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.92e-05	0.000249	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.79e-05	0.000239	CbGpPWpGaD
Vismodegib—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.78e-05	0.000237	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.78e-05	0.000237	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.76e-05	0.000236	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.73e-05	0.000234	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.71e-05	0.000231	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.69e-05	0.00023	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	2.68e-05	0.000229	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.65e-05	0.000226	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.63e-05	0.000225	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	2.62e-05	0.000224	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—GCLC—chronic obstructive pulmonary disease	2.61e-05	0.000223	CbGpPWpGaD
Vismodegib—SHH—Disease—IL6—chronic obstructive pulmonary disease	2.6e-05	0.000222	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.51e-05	0.000215	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.5e-05	0.000214	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.49e-05	0.000213	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.49e-05	0.000213	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.49e-05	0.000213	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	2.45e-05	0.000209	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.43e-05	0.000208	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.41e-05	0.000206	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—CTGF—chronic obstructive pulmonary disease	2.39e-05	0.000204	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.38e-05	0.000204	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.37e-05	0.000202	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.32e-05	0.000198	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.29e-05	0.000196	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.27e-05	0.000194	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.24e-05	0.000192	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.23e-05	0.00019	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.21e-05	0.000189	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	2.21e-05	0.000189	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.2e-05	0.000188	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	2.18e-05	0.000186	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.18e-05	0.000186	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	2.14e-05	0.000183	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.09e-05	0.000178	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	2.03e-05	0.000173	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	2e-05	0.000171	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.99e-05	0.00017	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.99e-05	0.00017	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	1.97e-05	0.000168	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.96e-05	0.000167	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.88e-05	0.000161	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.86e-05	0.000159	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.83e-05	0.000157	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.82e-05	0.000155	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.81e-05	0.000155	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.81e-05	0.000155	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.72e-05	0.000147	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.69e-05	0.000144	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.66e-05	0.000142	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.66e-05	0.000142	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.64e-05	0.00014	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.64e-05	0.00014	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.63e-05	0.00014	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	1.62e-05	0.000139	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	1.61e-05	0.000138	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.61e-05	0.000138	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.6e-05	0.000137	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.58e-05	0.000135	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.51e-05	0.000129	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.5e-05	0.000128	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	1.48e-05	0.000127	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	1.47e-05	0.000126	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.47e-05	0.000125	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.45e-05	0.000124	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.43e-05	0.000122	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.41e-05	0.000121	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.36e-05	0.000117	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.36e-05	0.000116	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.35e-05	0.000115	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.34e-05	0.000114	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.32e-05	0.000113	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.32e-05	0.000113	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.29e-05	0.00011	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.25e-05	0.000107	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.23e-05	0.000105	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.22e-05	0.000104	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.21e-05	0.000103	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.19e-05	0.000102	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.14e-05	9.73e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.14e-05	9.73e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.13e-05	9.67e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.12e-05	9.59e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.12e-05	9.54e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.11e-05	9.49e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—ALB—chronic obstructive pulmonary disease	1.09e-05	9.28e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.05e-05	8.94e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.05e-05	8.93e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.04e-05	8.89e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.04e-05	8.88e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.02e-05	8.68e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	1e-05	8.56e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.91e-06	8.47e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.91e-06	8.47e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.86e-06	8.42e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.78e-06	8.36e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.33e-06	7.98e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.26e-06	7.92e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.13e-06	7.81e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.11e-06	7.79e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.85e-06	7.56e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.81e-06	7.53e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	8.71e-06	7.44e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.64e-06	7.38e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	8.61e-06	7.35e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.51e-06	7.27e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.07e-06	6.9e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	7.95e-06	6.79e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.32e-06	6.26e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	6.74e-06	5.76e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	6.45e-06	5.51e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	6.41e-06	5.48e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.11e-06	5.22e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.02e-06	5.15e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	6.01e-06	5.14e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	5.87e-06	5.02e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	5.75e-06	4.92e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.62e-06	4.8e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.61e-06	4.8e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	5.48e-06	4.69e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.32e-06	4.55e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	5.25e-06	4.48e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.62e-06	3.09e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.46e-06	2.96e-05	CbGpPWpGaD
